연구동향 분석

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children

하석균 오경진 고광필 선용한 류일 Hann Tchah 전인상 김효정 안정민 조혜경 2018년

논문상세정보
인용/피인용

' Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children' 의 참고문헌

  • Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
    Ishiguro N [2017]
  • The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains
    Pereyre S [2013]
  • Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity
    Sánchez AR [2004]
  • Systemic quinolone antibiotics in children: a review of the use and safety
    Grady RW [2005]
  • Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012
    Zhao F [2013]
  • Steroids in severe pneumonia: a literature review
  • Side effects of corticosteroid therapy
    Buchman AL [2001]
  • Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children
    Lee KY [2006]
  • Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children
    Okada T [2012]
  • Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children
    Lung DC [2013]
  • Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
    이은 [2017]
  • Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia
    Narita M [2010]
  • Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients
    Kawai Y [2013]
  • Mycoplasma pneumoniae pneumonia in children
  • Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period
    Eun BW [2008]
  • Mycoplasma pneumoniae and its role as a human pathogen
    Waites KB [2004]
  • Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012
    Dumke R [2015]
  • Macrolide-resistant Mycoplasma pneumoniae, United States
    Zheng X [2015]
  • Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy
    Miyashita N [2013]
  • Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011
    Hong KB [2013]
  • Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae
    Hsieh YC [2012]
  • Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells
    Abe S [2000]
  • Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action
    Takizawa H [1995]
  • Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections
    Atkinson TP [2008]
  • Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae
    Yamazaki T [2016]
  • Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years
    김은경 [2015]
  • Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children
    Chironna M [2011]
  • Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children
    Luo Z [2014]
  • Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children
    Shan LS [2017]
  • Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
    유선영 [2014]
  • Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance
    Yoo SJ [2012]
  • Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae
    Suzuki S [2006]
  • Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan
    Matsuoka M [2004]
  • Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin
    Bradley JS [2014]
  • Antiinflammatory action of glucocorticoids-new mechanisms for old drugs
    Rhen T [2005]
  • Absence of tooth staining with doxycycline treatment in young children
    Volovitz B [2007]
  • A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients
    Matsubara K [2009]